ATE448244T1 - Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung - Google Patents
Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfungInfo
- Publication number
- ATE448244T1 ATE448244T1 AT00936995T AT00936995T ATE448244T1 AT E448244 T1 ATE448244 T1 AT E448244T1 AT 00936995 T AT00936995 T AT 00936995T AT 00936995 T AT00936995 T AT 00936995T AT E448244 T1 ATE448244 T1 AT E448244T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- derivatives
- nef
- induce
- protein
- Prior art date
Links
- 101710192141 Protein Nef Proteins 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 230000007812 deficiency Effects 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 206010057248 Cell death Diseases 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 102000008070 Interferon-gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 102000015696 Interleukins Human genes 0.000 abstract 1
- 108010063738 Interleukins Proteins 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940044627 gamma-interferon Drugs 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 229940047122 interleukins Drugs 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229930182852 proteinogenic amino acid Natural products 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9907012A FR2794370B1 (fr) | 1999-06-03 | 1999-06-03 | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
| PCT/FR2000/001514 WO2000075181A1 (fr) | 1999-06-03 | 2000-05-31 | FRAGMENTS PROTEIQUES POLYEPITOPIQUES DE LA PROTEINE Nef DE HIV, LEUR OBTENTION ET LEURS UTILISATIONS NOTAMMENT EN VACCINATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE448244T1 true ATE448244T1 (de) | 2009-11-15 |
Family
ID=9546327
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00938875T ATE554172T1 (de) | 1999-06-03 | 2000-05-31 | Proteinfragmente die polyepitope der proteine e6 und e7 von hpv umfassen, deren herstellung und verwendung insbesondere zur impfung |
| AT00936995T ATE448244T1 (de) | 1999-06-03 | 2000-05-31 | Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00938875T ATE554172T1 (de) | 1999-06-03 | 2000-05-31 | Proteinfragmente die polyepitope der proteine e6 und e7 von hpv umfassen, deren herstellung und verwendung insbesondere zur impfung |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6783763B1 (de) |
| EP (3) | EP1181314B8 (de) |
| AT (2) | ATE554172T1 (de) |
| AU (2) | AU5229400A (de) |
| CA (2) | CA2375602A1 (de) |
| DE (1) | DE60043299D1 (de) |
| ES (2) | ES2386803T3 (de) |
| FR (1) | FR2794370B1 (de) |
| WO (2) | WO2000075181A1 (de) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL105554A (en) * | 1992-05-05 | 1999-08-17 | Univ Leiden | Peptides of human papillomavirus for use in preparations elicit a human T cell response |
| CA2405363A1 (en) * | 2000-04-28 | 2001-11-08 | Ctl Immunotherapies Corp. | Epitope synchronization in antigen presenting cells |
| EP1355925A2 (de) * | 2000-12-08 | 2003-10-29 | Academisch Ziekenhuis Leiden | Lange peptide mit 22-45 aminosäureresten, die antigenspezifische immunreaktionen induzieren und/oder fördern |
| CA2431500C (en) | 2000-12-08 | 2016-06-07 | Sjoerd Hendrikus Van Der Burg | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| EP1213299A1 (de) * | 2000-12-08 | 2002-06-12 | Leids Universitair Medisch Centrum | Immunogene epitopen des menschlichen Papillom-Virus und deren Anwendung |
| FR2820425B1 (fr) * | 2001-02-08 | 2004-01-02 | Commissariat Energie Atomique | Melange de peptides issus d'une proteine nef et leurs applications |
| US6933123B2 (en) * | 2001-04-05 | 2005-08-23 | Yao Xiong Hu | Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| FR2824326B1 (fr) | 2001-05-04 | 2004-03-19 | Commissariat Energie Atomique | Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications |
| CN100412087C (zh) | 2001-07-13 | 2008-08-20 | 泰哲医药研究（深圳）有限公司 | 序列号2的生物活性肽 |
| SG185137A1 (en) * | 2001-07-13 | 2012-11-29 | Cms Peptides Patent Holding Company Ltd | Biologically active peptides |
| SI1421200T1 (sl) * | 2001-08-23 | 2007-04-30 | Merck & Co Inc | Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov |
| DE60238864D1 (de) | 2001-11-07 | 2011-02-17 | Mankind Corp | Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption |
| WO2004035795A1 (en) * | 2002-10-17 | 2004-04-29 | Bioleaders Corporation | Vector for anti-hpv vaccine and transformed microorganism by the vector |
| US20090028874A1 (en) * | 2003-12-24 | 2009-01-29 | Leiden University Medical Center | Synthetic Protein as Tumor-Specific Vaccine |
| AU2005222776A1 (en) * | 2003-12-31 | 2005-09-29 | Genimmune N.V. | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| EP1753845B1 (de) * | 2004-04-28 | 2018-01-03 | Headwaters Heavy Oil, LLC | Festbett-hydroprocessing-verfahren und -systeme und verfahren zur aufrüstung eines bestehenden festbettsystems |
| US10941353B2 (en) | 2004-04-28 | 2021-03-09 | Hydrocarbon Technology & Innovation, Llc | Methods and mixing systems for introducing catalyst precursor into heavy oil feedstock |
| MXPA06012528A (es) | 2004-04-28 | 2007-08-02 | Headwaters Heavy Oil Llc | Metodos y sistemas de hidroprocesamiento de lecho ebullente y metodos para mejorar un sistema de lecho ebullente existente. |
| WO2006063065A2 (en) | 2004-12-08 | 2006-06-15 | Gen-Probe Incorporated | Detection of nucleic acids from multiple types of human papillomaviruses |
| US20070037180A1 (en) * | 2005-02-10 | 2007-02-15 | Olle Nilsson | Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPV's |
| US7723472B2 (en) * | 2005-02-28 | 2010-05-25 | The Regents Of The University Of California | Extracellular matrix binding chimeric proteins and methods of use thereof |
| CN105063064B (zh) * | 2006-07-28 | 2024-09-24 | 宾夕法尼亚大学托管会 | 改进的疫苗及其使用方法 |
| US8877206B2 (en) | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
| EP2468763B1 (de) | 2007-05-31 | 2014-06-18 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | HPV-Epitope als Ziel für zervikale Tumoren infiltrierende T-Zellen zur Verwendung bei Impfstoffen |
| US8652482B2 (en) * | 2007-10-03 | 2014-02-18 | The Board Of Trustees Of The University Of Arkansas | HPV E6 protein T cell epitopes and uses thereof |
| EP2222336A2 (de) * | 2007-10-29 | 2010-09-01 | GENimmune N.V. | Verfahren und kits zur auslösung einer ctl-reaktion mit einem haupt-boost-schema |
| JP5267969B2 (ja) * | 2007-12-04 | 2013-08-21 | 学校法人慶應義塾 | 癌ワクチン |
| AU2009236306B2 (en) | 2008-04-17 | 2015-04-02 | Pds Biotechnology Corporation | Stimulation of an immune response by enantiomers of cationic lipids |
| EP2334317B1 (de) * | 2008-09-16 | 2017-06-14 | The Research Foundation Of State University Of New York | Geklammerte peptide und verfahren zu ihrer zusammensetzung |
| KR101471043B1 (ko) | 2009-01-08 | 2014-12-09 | 주식회사 바이오리더스 | 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균 |
| CN102482327B (zh) * | 2009-06-22 | 2014-10-29 | 财团法人卫生研究院 | 脂质化肿瘤相关抗原及其免疫治疗的组成物及方法 |
| US20120225090A1 (en) * | 2009-08-03 | 2012-09-06 | The Johns Hopkins University | Methods for enhancing antigen-specific immune responses |
| WO2012116220A2 (en) | 2011-02-24 | 2012-08-30 | Qiagen Gaithersburg, Inc. | Materials and methods for detection of hpv nucleic acid |
| ES2689799T3 (es) * | 2011-09-12 | 2018-11-15 | Pds Biotechnology Corporation | Formulaciones de vacunas particuladas |
| US9790440B2 (en) | 2011-09-23 | 2017-10-17 | Headwaters Technology Innovation Group, Inc. | Methods for increasing catalyst concentration in heavy oil and/or coal resid hydrocracker |
| AU2013274235B2 (en) | 2012-06-15 | 2018-01-18 | Samir N. Khleif | Cationic lipid vaccine compositions and methods of use |
| US9644157B2 (en) | 2012-07-30 | 2017-05-09 | Headwaters Heavy Oil, Llc | Methods and systems for upgrading heavy oil using catalytic hydrocracking and thermal coking |
| AU2013317805B2 (en) | 2012-09-21 | 2018-07-26 | Pds Biotechnology Corporation | Improved vaccine compositions and methods of use |
| CN103342738B (zh) * | 2013-07-24 | 2015-02-18 | 广州恒上医药技术有限公司 | 人乳头瘤病毒e6蛋白可诱发同源蛋白间交叉反应性抗体的精细表位肽 |
| WO2016005789A1 (en) * | 2014-07-07 | 2016-01-14 | Institut Pasteur | Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus- associated cancer stages |
| JP6325751B2 (ja) | 2014-11-04 | 2018-05-16 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 治療用ｈｐｖ１６ワクチン |
| AU2016309743B2 (en) | 2015-08-20 | 2019-02-07 | Janssen Vaccines & Prevention B.V. | Therapeutic HPV18 vaccines |
| US11414608B2 (en) | 2015-09-22 | 2022-08-16 | Hydrocarbon Technology & Innovation, Llc | Upgraded ebullated bed reactor used with opportunity feedstocks |
| US11414607B2 (en) | 2015-09-22 | 2022-08-16 | Hydrocarbon Technology & Innovation, Llc | Upgraded ebullated bed reactor with increased production rate of converted products |
| US11612652B2 (en) | 2015-11-13 | 2023-03-28 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
| US10517944B2 (en) | 2016-05-02 | 2019-12-31 | Janssen Vaccines & Prevention B.V. | Therapeutic HPV vaccine combinations |
| WO2017210649A1 (en) * | 2016-06-03 | 2017-12-07 | Etubics Corporation | Compositions and methods for the treatment of human papillomavirus (hpv)-associated diseases |
| US11421164B2 (en) | 2016-06-08 | 2022-08-23 | Hydrocarbon Technology & Innovation, Llc | Dual catalyst system for ebullated bed upgrading to produce improved quality vacuum residue product |
| AU2017281389B2 (en) | 2016-06-20 | 2024-02-22 | Isa Pharmaceuticals B.V. | Formulation of a peptide vaccine |
| CN108164587A (zh) * | 2016-12-07 | 2018-06-15 | 中国医学科学院肿瘤医院 | 新的hpv抗原表位 |
| KR102505534B1 (ko) | 2017-03-02 | 2023-03-02 | 하이드로카본 테크놀로지 앤 이노베이션, 엘엘씨 | 오염 침전물이 적은 업그레이드된 에뷸레이티드 베드 반응기 |
| US11732203B2 (en) | 2017-03-02 | 2023-08-22 | Hydrocarbon Technology & Innovation, Llc | Ebullated bed reactor upgraded to produce sediment that causes less equipment fouling |
| CN111655238A (zh) | 2017-12-05 | 2020-09-11 | Pds生物科技公司 | 用于刺激i型干扰素基因的包括阳离子脂质的方法和组合物 |
| CA3088837A1 (en) * | 2018-01-24 | 2019-08-01 | The Council Of The Queensland Institute Of Medical Research | Hpv immunotherapy |
| CA3057131C (en) | 2018-10-17 | 2024-04-23 | Hydrocarbon Technology And Innovation, Llc | Upgraded ebullated bed reactor with no recycle buildup of asphaltenes in vacuum bottoms |
| US12497569B2 (en) | 2022-05-26 | 2025-12-16 | Hydrocarbon Technology & Innovation, Llc | Method and system for mixing catalyst precursor into heavy oil using a high boiling hydrocarbon diluent |
| WO2024223299A2 (en) | 2023-04-26 | 2024-10-31 | Isa Pharmaceuticals B.V. | Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
| FR2641081A1 (de) * | 1988-12-23 | 1990-06-29 | Medgenix Group | |
| AU650868B2 (en) * | 1990-03-20 | 1994-07-07 | Behringwerke Aktiengesellschaft | Seroreactive epitopes of human papillomavirus (HPV) 16 proteins |
| US5932412A (en) * | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
| PT523391E (pt) | 1991-07-13 | 2003-08-29 | Dade Behring Marburg Gmbh | Utilizacao dos peptidos derivados dos genes hpv-16 e6 e e7 para fins de diagnostico |
| US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| IL105554A (en) * | 1992-05-05 | 1999-08-17 | Univ Leiden | Peptides of human papillomavirus for use in preparations elicit a human T cell response |
| WO1995011255A1 (en) * | 1993-10-19 | 1995-04-27 | Ajinomoto Co., Inc. | Peptide capable of inducing immune response against hiv and aids preventive or remedy containing the peptide |
| AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
| DE69723434T2 (de) * | 1996-04-26 | 2004-05-19 | Rijksuniversiteit Te Leiden | Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope |
| AUPO390396A0 (en) * | 1996-11-29 | 1996-12-19 | Csl Limited | Novel promiscuous T helper cell epitopes |
| FR2771640B1 (fr) * | 1997-12-03 | 2000-02-11 | Inst Nat Sante Rech Med | Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques |
-
1999
- 1999-06-03 FR FR9907012A patent/FR2794370B1/fr not_active Expired - Lifetime
-
2000
- 2000-05-31 AU AU52294/00A patent/AU5229400A/en not_active Abandoned
- 2000-05-31 DE DE60043299T patent/DE60043299D1/de not_active Expired - Lifetime
- 2000-05-31 AU AU54110/00A patent/AU5411000A/en not_active Abandoned
- 2000-05-31 CA CA002375602A patent/CA2375602A1/fr not_active Abandoned
- 2000-05-31 AT AT00938875T patent/ATE554172T1/de active
- 2000-05-31 WO PCT/FR2000/001514 patent/WO2000075181A1/fr not_active Ceased
- 2000-05-31 EP EP00936995A patent/EP1181314B8/de not_active Expired - Lifetime
- 2000-05-31 EP EP00938875A patent/EP1183368B1/de not_active Expired - Lifetime
- 2000-05-31 CA CA002375627A patent/CA2375627A1/en not_active Abandoned
- 2000-05-31 ES ES00938875T patent/ES2386803T3/es not_active Expired - Lifetime
- 2000-05-31 EP EP10177363.8A patent/EP2267132B1/de not_active Expired - Lifetime
- 2000-05-31 WO PCT/FR2000/001513 patent/WO2000075336A2/fr not_active Ceased
- 2000-05-31 AT AT00936995T patent/ATE448244T1/de not_active IP Right Cessation
- 2000-05-31 US US09/980,523 patent/US6783763B1/en not_active Expired - Lifetime
- 2000-05-31 ES ES10177363.8T patent/ES2509901T3/es not_active Expired - Lifetime
-
2004
- 2004-06-02 US US10/858,384 patent/US7288258B2/en not_active Expired - Fee Related
-
2007
- 2007-09-21 US US11/859,320 patent/US20080248044A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1181314A1 (de) | 2002-02-27 |
| FR2794370B1 (fr) | 2003-10-17 |
| US20080248044A1 (en) | 2008-10-09 |
| EP1183368B1 (de) | 2012-04-18 |
| FR2794370A1 (fr) | 2000-12-08 |
| EP1183368A2 (de) | 2002-03-06 |
| WO2000075336A3 (fr) | 2001-07-26 |
| AU5229400A (en) | 2000-12-28 |
| EP1181314B8 (de) | 2010-02-17 |
| US20050033025A1 (en) | 2005-02-10 |
| US7288258B2 (en) | 2007-10-30 |
| EP2267132A2 (de) | 2010-12-29 |
| CA2375627A1 (en) | 2000-12-14 |
| CA2375602A1 (fr) | 2000-12-14 |
| ES2509901T3 (es) | 2014-10-20 |
| WO2000075181A1 (fr) | 2000-12-14 |
| EP1181314B1 (de) | 2009-11-11 |
| DE60043299D1 (de) | 2009-12-24 |
| ATE554172T1 (de) | 2012-05-15 |
| US6783763B1 (en) | 2004-08-31 |
| EP2267132B1 (de) | 2014-07-16 |
| EP2267132A3 (de) | 2011-04-20 |
| AU5411000A (en) | 2000-12-28 |
| ES2386803T3 (es) | 2012-08-31 |
| WO2000075336A2 (fr) | 2000-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE448244T1 (de) | Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung | |
| Legler et al. | Chemokines: chemistry, biochemistry and biological function | |
| FI932678A7 (fi) | Alfaviruksiin perustuvia DNA-ilmentämissysteemejä | |
| HRP20201228T1 (hr) | Nova imunoterapija protiv nekoliko tumora, uključujući tumore neurona i mozga | |
| ATE386800T1 (de) | Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
| JPS60115528A (ja) | ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物 | |
| BR0314373A (pt) | Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
| RU2401307C1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pFK2, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ПЕПТИДА, ЯВЛЯЮЩЕГОСЯ АНАЛОГОМ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ПЕПТИДА И РЕКОМБИНАНТНЫЙ ПЕПТИД, АНАЛОГ ФРАГМЕНТА КАППА-КАЗЕИНА ЧЕЛОВЕКА, ОБЛАДАЮЩИЙ АПОПТОТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К РАКОВЫМ КЛЕТКАМ | |
| ES2561483T3 (es) | Antígenos mutantes de GAS57 y anticuerpos de GAS57 | |
| ATE169958T1 (de) | Herstellung der p1 proteine und impfstoffe gegen gonorrhöe | |
| KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
| ATE351904T1 (de) | Einem peptid aus antigen muc-1 entsprechende dns zur auslösung einer immunreaktion gegen tumorzellen | |
| JPS61225130A (ja) | 鶏卵卵白システインの単離方法およびこれを含有するウイルス感染の処置剤 | |
| DK35891A (da) | Praktisk taget rent, antigenisk peptid eller protein med en epitop af haemophilus influenzae, dets fremstilling og anvendelse | |
| JPS6338330B2 (de) | ||
| Holtet et al. | Receptor‐binding domain of human α2‐macroglobulin Expression, folding and biochemical characterization of a high‐affinity recombinant derivative | |
| CN110078793A (zh) | 一种具有抗衰老和修复作用的多肽及其用途 | |
| BR9713540A (pt) | Procedimento para a expressão do gene do vìrus da dengue | |
| DE3751646D1 (de) | Rekombinantes Produkt | |
| BR0016289A (pt) | Vìrus sentinela i do vìrus da hepatite | |
| EP1749833A1 (de) | Super-Antigene aus dem E2-Spike-Protein des SARS-Coronavirus | |
| DE60234847D1 (de) | N-desoxyribosyltransferase aus lactobacillus, entsprechende nukleinsäuren darauf und ihre verwendungen | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| Riding et al. | A strategy for purification and peptide sequence analysis of bovine ephemeral fever virus structural proteins | |
| WO2001060851A1 (en) | Staphylococcal enterotoxin sec-ser, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |